[96a5a0]: / output / chiaCancer / identified / NCT02804646_identified.json

Download this file

509 lines (509 with data), 25.4 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
{
"info": {
"nct_id": "NCT02804646",
"official_title": "Recombinant Human Endostatin Durative Transfusion Combined With Pemetrexed Plus Cisplatin or Carboplatin in the First-line Treatment of Advanced Lung Adenocarcinoma With Wild-type EGFR or ALK-negative",
"inclusion_criteria": "* 1) histologically confirmed (patients not receiving a single sputum cytology diagnosis) non-small cell lung cancer patients,with wild-type EGFR and ALK-negative; 2) According to IASLC2009 new TNM staging of lung cancer stage ⅢB or Ⅳ, previously untreated or relapsed after 1 year of lung cancer resection; 3) have at least one evaluable lesions,according to version 1.1 of the standard in accordance with a judgment RECIST(longest diameter on a spiral CT at least 10mm,on a regular CT longest diameter at least 20mm); 4) Male or female, aged 18 to 75 years; 5) ECOG PS 0 or 1; 6) expected survival at least 3 months; 7) adequate hematological function: absolute neutrophil count (ANC) at least 2×10^9/L and platelet count at least 100×10^9/L and hemoglobin at least 9 g/dL; 8) adequate liver function: total bilirubin less than upper limit of normal (ULN); AST and ALT less than 2.5 times upper limit of normal (ULN); alkaline phosphatase less than 5 times the upper limit of normal (ULN); 9) adequate renal function: serum creatinine less than upper limit of normal (ULN) or calculated creatinine clearance at least 60 mL/min; 10) ECG is normal, there is no non-healing wounds on the body; 11) had not received previous treatment anticancer drugs, or had only received for previous non-metastatic tumors adjuvant or neoadjuvant chemotherapy, but when you start to study treatment has ended more than 6 months; 12) have conducted previous surgery patients required to study treatment was started more than four weeks, and the patient had recovered; 13) have an intact uterus in women prior to enrollment in the study must have a negative pregnancy test result (unless it is already 24 months of amenorrhea) within 28 days. If the pregnancy test from the first administration more than seven days, urine pregnancy test is required for authentication (less than 7 days before the first dose); 14) previous to biological agents, particularly E.coli genetically engineered products without serious allergic reactions; 15) signed informed consent.\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
"exclusion_criteria": "* 1) pregnancy, breast-feeding women, or female patients of childbearing potential but did not take contraceptive measures;2) existing severe acute infection and is not controlled; or purulent and chronic infection, delayed healing wounds; 3) the original severe heart disease, including congestive heart failure, uncontrolled high-risk arrhythmias, unstable angina, myocardial infarction, severe heart valve disease and resistant hypertension; 4) suffering from neurological and psychiatric diseases or mental disorders is not easy to control, poor compliance, and can not be described with treatment responders; primary brain or central nervous metastasis disease has not been controlled, with significant cranial hypertension or neuropsychiatric symptoms; 5) have bleeding tendencies; 6) other researchers believe that patients should not participate in the present trial.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* 1) histologically confirmed (patients not receiving a single sputum cytology diagnosis) non-small cell lung cancer patients,with wild-type EGFR and ALK-negative; 2) According to IASLC2009 new TNM staging of lung cancer stage ⅢB or Ⅳ, previously untreated or relapsed after 1 year of lung cancer resection; 3) have at least one evaluable lesions,according to version 1.1 of the standard in accordance with a judgment RECIST(longest diameter on a spiral CT at least 10mm,on a regular CT longest diameter at least 20mm); 4) Male or female, aged 18 to 75 years; 5) ECOG PS 0 or 1; 6) expected survival at least 3 months; 7) adequate hematological function: absolute neutrophil count (ANC) at least 2×10^9/L and platelet count at least 100×10^9/L and hemoglobin at least 9 g/dL; 8) adequate liver function: total bilirubin less than upper limit of normal (ULN); AST and ALT less than 2.5 times upper limit of normal (ULN); alkaline phosphatase less than 5 times the upper limit of normal (ULN); 9) adequate renal function: serum creatinine less than upper limit of normal (ULN) or calculated creatinine clearance at least 60 mL/min; 10) ECG is normal, there is no non-healing wounds on the body; 11) had not received previous treatment anticancer drugs, or had only received for previous non-metastatic tumors adjuvant or neoadjuvant chemotherapy, but when you start to study treatment has ended more than 6 months; 12) have conducted previous surgery patients required to study treatment was started more than four weeks, and the patient had recovered; 13) have an intact uterus in women prior to enrollment in the study must have a negative pregnancy test result (unless it is already 24 months of amenorrhea) within 28 days. If the pregnancy test from the first administration more than seven days, urine pregnancy test is required for authentication (less than 7 days before the first dose); 14) previous to biological agents, particularly E.coli genetically engineered products without serious allergic reactions; 15) signed informed consent.",
"criterions": [
{
"exact_snippets": [
"histologically confirmed",
"non-small cell lung cancer"
],
"criterion": "non-small cell lung cancer",
"requirement_type": "confirmation",
"expected_value": true
},
{
"exact_snippets": [
"wild-type EGFR"
],
"criterion": "EGFR",
"requirement_type": "mutation status",
"expected_value": "wild-type"
},
{
"exact_snippets": [
"ALK-negative"
],
"criterion": "ALK",
"requirement_type": "mutation status",
"expected_value": "negative"
},
{
"exact_snippets": [
"IASLC2009 new TNM staging of lung cancer stage ⅢB or Ⅳ"
],
"criterion": "TNM staging",
"requirement_type": "stage",
"expected_value": [
"ⅢB",
"Ⅳ"
]
},
{
"exact_snippets": [
"previously untreated or relapsed after 1 year of lung cancer resection"
],
"criterion": "treatment history",
"requirement_type": "status",
"expected_value": [
"previously untreated",
"relapsed after 1 year of lung cancer resection"
]
},
{
"exact_snippets": [
"at least one evaluable lesions"
],
"criterion": "evaluable lesions",
"requirement_type": "quantity",
"expected_value": true
},
{
"exact_snippets": [
"RECIST",
"longest diameter on a spiral CT at least 10mm",
"on a regular CT longest diameter at least 20mm"
],
"criterion": "lesion size",
"requirement_type": "measurement",
"expected_value": "RECIST 1.1 standards"
},
{
"exact_snippets": [
"Male or female, aged 18 to 75 years"
],
"criterion": "age",
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18
},
{
"operator": "<=",
"value": 75
}
]
}
},
{
"exact_snippets": [
"ECOG PS 0 or 1"
],
"criterion": "ECOG performance status",
"requirement_type": "score",
"expected_value": [
"0",
"1"
]
},
{
"exact_snippets": [
"expected survival at least 3 months"
],
"criterion": "expected survival",
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 3
}
},
{
"exact_snippets": [
"adequate hematological function",
"absolute neutrophil count (ANC) at least 2×10^9/L"
],
"criterion": "absolute neutrophil count",
"requirement_type": "count",
"expected_value": {
"operator": ">=",
"value": 2000000000.0
}
},
{
"exact_snippets": [
"adequate hematological function",
"platelet count at least 100×10^9/L"
],
"criterion": "platelet count",
"requirement_type": "count",
"expected_value": {
"operator": ">=",
"value": 100000000000.0
}
},
{
"exact_snippets": [
"adequate hematological function",
"hemoglobin at least 9 g/dL"
],
"criterion": "hemoglobin",
"requirement_type": "level",
"expected_value": {
"operator": ">=",
"value": 9
}
},
{
"exact_snippets": [
"adequate liver function",
"total bilirubin less than upper limit of normal (ULN)"
],
"criterion": "total bilirubin",
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 1
}
},
{
"exact_snippets": [
"adequate liver function",
"AST and ALT less than 2.5 times upper limit of normal (ULN)"
],
"criterion": "AST and ALT",
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 2.5
}
},
{
"exact_snippets": [
"adequate liver function",
"alkaline phosphatase less than 5 times the upper limit of normal (ULN)"
],
"criterion": "alkaline phosphatase",
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 5
}
},
{
"exact_snippets": [
"adequate renal function",
"serum creatinine less than upper limit of normal (ULN)"
],
"criterion": "serum creatinine",
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 1
}
},
{
"exact_snippets": [
"adequate renal function",
"calculated creatinine clearance at least 60 mL/min"
],
"criterion": "creatinine clearance",
"requirement_type": "rate",
"expected_value": {
"operator": ">=",
"value": 60
}
},
{
"exact_snippets": [
"ECG is normal"
],
"criterion": "ECG",
"requirement_type": "status",
"expected_value": "normal"
},
{
"exact_snippets": [
"no non-healing wounds on the body"
],
"criterion": "non-healing wounds",
"requirement_type": "presence",
"expected_value": false
},
{
"exact_snippets": [
"had not received previous treatment anticancer drugs",
"only received for previous non-metastatic tumors adjuvant or neoadjuvant chemotherapy",
"treatment has ended more than 6 months"
],
"criterion": "previous anticancer drug treatment",
"requirement_type": "history",
"expected_value": "none or ended >6 months ago"
},
{
"exact_snippets": [
"previous surgery patients required to study treatment was started more than four weeks",
"patient had recovered"
],
"criterion": "previous surgery",
"requirement_type": "recovery",
"expected_value": "recovered >4 weeks ago"
},
{
"exact_snippets": [
"intact uterus in women",
"negative pregnancy test result",
"within 28 days"
],
"criterion": "pregnancy test",
"requirement_type": "result",
"expected_value": "negative within 28 days"
},
{
"exact_snippets": [
"previous to biological agents",
"E.coli genetically engineered products without serious allergic reactions"
],
"criterion": "allergic reactions to biological agents",
"requirement_type": "history",
"expected_value": "none"
},
{
"exact_snippets": [
"signed informed consent"
],
"criterion": "informed consent",
"requirement_type": "status",
"expected_value": true
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": [
"Healthy volunteers allowed"
],
"criterion": "volunteer health status",
"requirement_type": "allowance",
"expected_value": true
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": [
"minimum age of 18 Years"
],
"criterion": "age",
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18
}
}
]
},
{
"line": "Must have maximum age of 75 Years",
"criterions": [
{
"exact_snippets": [
"maximum age of 75 Years"
],
"criterion": "age",
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 75
}
}
]
}
],
"exclusion_lines": [
{
"line": "* 1) pregnancy, breast-feeding women, or female patients of childbearing potential but did not take contraceptive measures;2) existing severe acute infection and is not controlled; or purulent and chronic infection, delayed healing wounds; 3) the original severe heart disease, including congestive heart failure, uncontrolled high-risk arrhythmias, unstable angina, myocardial infarction, severe heart valve disease and resistant hypertension; 4) suffering from neurological and psychiatric diseases or mental disorders is not easy to control, poor compliance, and can not be described with treatment responders; primary brain or central nervous metastasis disease has not been controlled, with significant cranial hypertension or neuropsychiatric symptoms; 5) have bleeding tendencies; 6) other researchers believe that patients should not participate in the present trial.",
"criterions": [
{
"exact_snippets": [
"pregnancy"
],
"criterion": "pregnancy",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"breast-feeding women"
],
"criterion": "breastfeeding",
"requirement_type": "status",
"expected_value": true
},
{
"exact_snippets": [
"female patients of childbearing potential",
"did not take contraceptive measures"
],
"criterion": "contraceptive measures",
"requirement_type": "usage",
"expected_value": false
},
{
"exact_snippets": [
"existing severe acute infection",
"is not controlled"
],
"criterion": "severe acute infection",
"requirement_type": "control",
"expected_value": false
},
{
"exact_snippets": [
"purulent and chronic infection"
],
"criterion": "purulent and chronic infection",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"delayed healing wounds"
],
"criterion": "delayed healing wounds",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"original severe heart disease"
],
"criterion": "severe heart disease",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"congestive heart failure"
],
"criterion": "congestive heart failure",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"uncontrolled high-risk arrhythmias"
],
"criterion": "high-risk arrhythmias",
"requirement_type": "control",
"expected_value": false
},
{
"exact_snippets": [
"unstable angina"
],
"criterion": "unstable angina",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"myocardial infarction"
],
"criterion": "myocardial infarction",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"severe heart valve disease"
],
"criterion": "severe heart valve disease",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"resistant hypertension"
],
"criterion": "resistant hypertension",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"suffering from neurological and psychiatric diseases",
"is not easy to control"
],
"criterion": "neurological and psychiatric diseases",
"requirement_type": "control",
"expected_value": false
},
{
"exact_snippets": [
"mental disorders",
"is not easy to control"
],
"criterion": "mental disorders",
"requirement_type": "control",
"expected_value": false
},
{
"exact_snippets": [
"poor compliance"
],
"criterion": "compliance",
"requirement_type": "quality",
"expected_value": "poor"
},
{
"exact_snippets": [
"primary brain or central nervous metastasis disease",
"has not been controlled"
],
"criterion": "brain or central nervous metastasis disease",
"requirement_type": "control",
"expected_value": false
},
{
"exact_snippets": [
"significant cranial hypertension"
],
"criterion": "cranial hypertension",
"requirement_type": "severity",
"expected_value": "significant"
},
{
"exact_snippets": [
"neuropsychiatric symptoms"
],
"criterion": "neuropsychiatric symptoms",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"bleeding tendencies"
],
"criterion": "bleeding tendencies",
"requirement_type": "presence",
"expected_value": true
},
{
"exact_snippets": [
"other researchers believe that patients should not participate"
],
"criterion": "researcher opinion",
"requirement_type": "participation recommendation",
"expected_value": false
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}